Skip to main
DOCS
DOCS logo

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 18 analyst ratings
Hold
Strong Buy 11%
Buy 39%
Hold 39%
Sell 6%
Strong Sell 6%

Bulls say

Doximity has experienced significant growth in its point-of-care (POC) and formulary offerings, which expanded by over 100% during the recent buying season, indicating strong demand for its services among medical professionals. The company's stock has shown resilience and upward movement, with a 3.2% increase since September 8, suggesting positive market sentiment following the recent Memorandum. Additionally, the achievable and potentially favorable 2Q guidance, coupled with increased visibility from expanded offerings, positions Doximity for continued success in the evolving healthcare landscape.

Bears say

Doximity Inc. is facing a challenging financial outlook due to downward guidance revisions from its pharmaceutical clients, attributed to the current uncertain economic environment. The company's shares are perceived as expensive compared to its software peers, raising concerns about potential volatility if the financial results fall short of investor expectations. Additionally, there is significant pressure on Doximity to provide positive performance metrics, as any failure to exceed or raise guidance may lead to negative market reaction.

Doximity (DOCS) has been analyzed by 18 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 39% recommend Buy, 39% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Hold based on their latest research and market trends.

According to 18 analysts, Doximity (DOCS) has a Hold consensus rating as of Oct 22, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $70.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $70.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.